| Literature DB >> 31867079 |
Saurabh Arora1, Nishikant A Damle1, Rachna Meel2, Sanjay Sharma3, Seema Sen4, Chandrasekar Bal1, Kanak Lata1, Sneha Prakash1,5, Divya Yadav1, Meivel Angamuthu1.
Abstract
Immunoglobulin G4 (IgG4)-related diseases are a spectrum of systemic inflammatory conditions of unknown etiology, which are characterized by infiltration of tissues by IgG4 plasma cells and sclerosing inflammation (Cheuk and Chan Adv Anat Pathol 17:303-32, 2010). Although this condition was initially described in relation to autoimmune pancreatitis, now it has been reported in almost every organ system of body (Zen and Nakanuma Am J Surg Pathol 34:1812-9, 2010, Masaki et al. Ann Rheuma Dis 68:1310-5, 2009). Orbital involvement by IgG4 disease can involve extraocular muscles (EOM), lacrimal glands, conjunctiva, eyelids, infraorbital nerve, orbital fat, and nasolacrimal system (McNab and McKelvie. Ophthal Plast Reconstr Surg 31:167-78, 2015, Katsura et al. Neuroradiology 54:873-82, 2012). The basis of using 68Ga-DOTANOC PET/CT in IgG4 orbital disease is the known expression of somatostatin receptors in chronic inflammatory cells (Cuccurullo et al. Indian J Radiol Imaging 27:509-16, 2017) and also avidity shown previously in other IgG4-related diseases (Cheng et al. Clin Nucl Med 43:773-6, 2018). © Korean Society of Nuclear Medicine 2019.Entities:
Keywords: 68Ga-DOTANOC PET/CT; Orbital IgG4 disease; Somatostatin receptors
Year: 2019 PMID: 31867079 PMCID: PMC6898689 DOI: 10.1007/s13139-019-00611-z
Source DB: PubMed Journal: Nucl Med Mol Imaging ISSN: 1869-3474